Access cutting-edge small cell lung cancer treatment through this clinical trial at a research site in Daphne. Study-provided care at no cost to qualified participants.
Access small cell lung cancer specialists in Daphne at no cost
This study follows strict safety protocols and ethical guidelines
All study-related small cell lung cancer treatment provided free
The Purpose of the Study is to Compare the Efficacy and Safety of BMS-986489 (Anti-fucosyl-GM1+ Nivolumab Fixed Dose Combination) in Combination with Carboplatin plus Etoposide to that of Atezolizumab with Carboplatin plus Etoposide as First-Line Therapy in Participants with Extensive-Stage Small Cell Lung Cancer.
Sponsor: Bristol-Myers Squibb
Check if you qualify for this small cell lung cancer clinical trial in Daphne, AL
If you're searching for small cell lung cancer treatment options in Daphne, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Daphne research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.